Body mass index and mortality in chronic obstructive pulmonary disease: A dose-response meta-analysis

Medicine (United States)

Volumn 95, Issue 28, 2016, Pages

  Guo, Yibin ^a   Zhang, Tianyi ^a   Wang, Zhiyong ^a   Yu, Feifei ^a   Xu, Qin ^a   Guo, Wei ^a   Wu, Cheng ^a   He, Jia ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

body mass index; chronic obstructive pulmonary disease; dose response meta analysis; mortality

Indexed keywords

ARTICLE; BODY MASS; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; MORTALITY; MORTALITY RISK; NUTRITIONAL SUPPORT; OBESITY; PRIORITY JOURNAL; PROGNOSIS; SYSTEMATIC REVIEW; UNDERWEIGHT; FEMALE; MALE; META ANALYSIS;

BODY MASS INDEX; FEMALE; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84980021889     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000004225     Document Type: Article

References (30)

1. The Asia Pacific COPD Roundtable Group Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: An Asia-Pacific perspective. Respirology 2005;10:9-17.
2. Flegal KM, Kit BK, Orpana H, et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013;309:71-82.
3. Cao C, Wang R, Wang JM, et al. Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PloS One 2012;7:8.
4. Liu XM, Liu YJ, Zhan J, et al. Overweight, obesity and risk of all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus: a dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol 2014;30:35-45.
5. Bagheri M, Speakman JR, Shabbidar S, et al. A dose-response metaanalysis of the impact of body mass index on stroke and all-cause mortality in stroke patients: a paradox within a paradox. Obes Rev 2015;16:41623.
6. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis. Am J Kidney Dis 2007;49:581-91.
7. Galesanu RG, Bernard S, Marquis K, et al. Obesity in chronic obstructive pulmonary disease: is fatter really better? Can Resp J 2014;21:297-301.
8. Wells G, Shea B, O'Connel D, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses. Ottawa, ON:Ottawa Hospital Research Institute; 2009.
9. Bianchini F, Kaaks R, Vainio H. Weight control and physical activity in cancer prevention. Obes Rev 2002;3:5-8.
10. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J 2006;6:40-57.
11. Orsini N, Li R, Wolk A, et al. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012;175:66-73.
12. Higgins JPT, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002;21:1539-58.
13. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
14. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:455-63.
15. Chailleux E, Laaban J-P, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest 2003;123:1460-6.
16. Chang CL, Sullivan GD, Karalus NC, et al. Audit of acute admissions of chronic obstructive pulmonary disease: inpatient management and outcome. Int Med J 2007;37:236-41.
17. Collins PF, Stratton RJ, Kurukulaaratchy R, et al. Deprivation is an independent predictor of 1-year mortality in outpatients with chronic obstructive pulmonary disease. Thorax 2010;65:A74-5.
18. Gunen H, Hacievliyagil SS, Kosar F, et al. Factors affecting survival of hospitalised patients with COPD. Eur Resp J 2005;26:234-41.
19. Hallin R, Gudmundsson G, Ulrik CS, et al. Nutritional status and longterm mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Resp Med 2007;101:1954-60.
20. Jordan JG Jr, Mann JR. Obesity and mortality in persons with obstructive lung disease using data from the NHANES III. South Med J 2010;103: 323-30.
21. Lainscak M, Haehling Sv, Doehner W, et al. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle 2011; 2:81-6.
22. Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Resp Crit Care Med 1999;160:1856-61.
23. Marti S, Munoz X, Rios J, et al. Body weight and comorbidity predict mortality in COPD patients treated with oxygen therapy. Eur Resp J 2006;27:689-96.
24. Schembri S, Anderson W, Morant S, et al. A predictive model of hospitalisation and death from chronic obstructive pulmonary disease. Resp Med 2009;103:1461-7.
25. Yamauchi Y. Paradoxical association between body mass index and inhospital mortality in elderly patients with chronic obstructive pulmonary disease in Japan. Int J Chronic Obstr Pulm Dis 2014;9:1337-46.
26. Prescott E, Almdal T, Mikkelsen KL, et al. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Resp J 2002;20:539-44.
27. Ringbaek TJ, Viskum K, Lange P. BMI and oral glucocorticoids as predictors of prognosis in COPD patients on long-term oxygen therapy. Chronic Resp Dis 2004;1:71-8.
28. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:282-3.
29. Schols AM, Broekhuizen R, Weling-Scheepers CA, et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005;82:53-9.
30. Sin DD, Jones RL, Man SFP. Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Int Med 2002;162:1477-81.